Epigenetic signatures of regional tau pathology and cognition in the aging and pathological brain.
Abstract
Primary age-related tauopathy (PART) and Alzheimers disease (AD) share hippocampal phospho-tau (p-tau) pathology but differ in p-tau extent and {beta}-amyloid presence. As a result, PART uniquely enables investigation of amyloid-independent p-tau mechanisms during brain aging. We conducted an epigenome-wide association (EWAS) study of PART, nominating 13 new and robust p-tau/methylation associations. We then jointly analyzed PART and AD epigenomes to develop novel epigenetic clocks, "TauAge", that predict p-tau severity in region-specific, age-, and {beta}-amyloid-independent manners. Integrative transcriptomic analyses revealed that genes involved in synaptic transmission are related to hippocampal p-tau severity in both PART and AD, while neuroinflammatory genes are related to frontal cortex p-tau severity in AD only. Further, a machine learning classifier trained on PART-vs-AD epigenetic differences stratifies an independent cohort of neuropathologically indeterminate cases into pathological subgroups with disparity in cognitive impairment. Together, these findings demonstrate the brain epigenomes substantial role in linking tau pathology to cognitive outcomes in aging and AD.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper investigates the epigenetic mechanisms underlying tau pathology and cognitive outcomes in aging and Alzheimer's disease, which is relevant to understanding age-related diseases. However, it primarily focuses on the associations and mechanisms rather than addressing the root causes of aging or proposing interventions for lifespan extension. The findings contribute solid insights into the relationship between epigenetics and tau pathology but do not represent a major breakthrough in the field.
Author of this paper? Send a correction.